Equity
€759,161 ▼ 2.1%
NANH paid out €305,775 in dividends. That is 106% of the 2025 profit.
NANH
Lifetime
8 annual accounts with figures on one time axispeak €461,546 (2024)
€440,748▼ 4.5%
peak €313,275 (2024)
€289,527▼ 7.6%
peak €775,410 (2024)
€759,161▼ 2.1%
€680,918▲ 77.7%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
26-08-202626 days late
2025micro format
Dividend €305,775Debts from €383,258 to €680,918
Key points
from the 2025 annual accountsTurnover
≈ €660,000 estimated
The micro format states no turnover.
Debts
€680,918 ▲ 77.7%
Debts rose by €297,660 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Filings
8 annual accounts 8 late
The 2019 accounts came latest: 84 days after the end of the period.
Starting capital
€18,600 186 shares
Position in the sector
€289,527
Higher net result than 95% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,783 companies had the same profile as NANH has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,783 companies, not a prediction for NANH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Manager, since 28-05-2018
Manager, since 28-05-2018
- 93 sharesdeed of 30-05-2018
- 93 sharesdeed of 30-05-2018
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0696833746
Amendment of the articles · Legal-form change · Resignations & appointments
General meeting of 29-09-2022 · Gazette deed
Incorporation
Founding capital of €18,600, 186 shares · Founders: and · Appointments: (manager) and (manager) · published on 30-05-2018 · Gazette deed
First establishment
Place de la Villette 3, Charleroi
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NANH Charleroi | €1.4m | €440,748 | 52.7% | - |
| DR. BARTH JOERI Bruges | €1.4m | €434,020 | 21.7% | - |
| Dr. Barbara Craggs, Plastisch chirurg Jabbeke | €1.4m | €454,682 | 32.6% | - |
| DOCTEURS HABRAN-PARZIBUT Liège | €1.5m | €463,733 | 33.9% | - |
| Drs Namur-Marques Liège | €1.3m | €480,145 | 93.7% | - |
| DOKTER LAURENCE BLADT RADIOLOOG Destelbergen | €1.3m | €498,140 | 93.6% | - |
| DOCTEUR PRINCEO DK Mouscron | €1.4m | €453,274 | 55.7% | - |
These companies have the same main activity as NANH: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.5m, founded between 2017 and 2020.
Official details
Source: KBO- Status
- Active since 28-05-2018Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.276.256.7356001 Charleroi, since 28-05-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 02-10-2025
Insights on NANH
NANH files the micro format. That format states no turnover. The gross margin rose from €176,091 in 2018 to €440,748 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NANH
- What is the company number of NANH?
- The company number of NANH is 0696.833.746. The VAT number is the same number with BE in front: BE 0696.833.746.
- Where is NANH based?
- The registered office is at Place de la Villette 3, 6001 Charleroi.Company details
- What does NANH do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of NANH?
- NANH is a private limited company (BV).
- When was NANH founded?
- NANH was founded on 28-05-2018.
- Is NANH still active?
- Yes, NANH is an active enterprise in the KBO register.
- What is the turnover of NANH?
- The turnover in financial year 2025 is ≈ €660,000. This figure is estimated from the gross margin of €440,748 and 31 comparable companies (NACE 86220). It probably lies between €590,000 and €920,000.Financials
- Is NANH profitable?
- In financial year 2025, NANH made a profit of €289,527.
- Where can I find the annual accounts of NANH?
- NANH filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NANH due?
- NANH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.